Marc H. Hedrick
President, CEO & DirectorDr. Marc H. Hedrick, M.D., M.B.A., serves as President of Cerenome, Inc. (formerly known as Plus Therapeutics, Inc.) (also known as Cytori Therapeutics, Inc.) since May 2004 and has been its Chief Executive Officer since April 2, 2014. Dr. Hedrick had been Member of Scientific Board at Cerenome, Inc. (formerly known as Plus Therapeutics, Inc.) Dr. Hedrick had been Principal Financial and Accounting Officer at Cerenome, Inc. (formerly known as Plus Therapeutics, Inc.) since August 09, 2019 until November 6, 2019. Dr. Hedrick served as the Principal Financial Officer of Cerenome, Inc. (formerly known as Plus Therapeutics, Inc.) from August 2014 to September 2, 2014. Dr. Hedrick joined Cerenome, Inc. (formerly known as Plus Therapeutics, Inc.) on October 2002. He was Chief Scientific Officer since October 2002. He co-founded StemSource Inc. and served as the President and Chief Executive Officer and Director. He was Chief Scientific Officer and Medical Director of Macropore Biosurgery. He is a Plastic Surgeon and was an Associate Professor of Surgery and Pediatrics at the University of California, Los Angeles (UCLA) and from 1998 to 2005, has directed the Laboratory of Regenerative Bioengineering and Repair for the Department of Surgery at UCLA. Dr. Hedrick has been a Director of Cerenome, Inc. (formerly known as Plus Therapeutics, Inc.) since October 2002. He obtained his MD degree from the University of Texas Southwestern Medical School, Dallas and an M.B.A. from UCLA Anderson School of Management.
Positions
- Company NameCerenome, Inc.Stock CodeCNSYPositionPresident, CEO & DirectorColleagues
- RJRichard J. HawkinsIndependent Chairman of the Board
- AJAndrew J. SimsVP & CFO
- EJEric J. DanielsChief Development Officer & COO
- RHRuss HavranekExecutive Vice President of Commercial and Corporate Strategy
- RARonald A. AndrewsChief Business Officer & Director
- AVAn van Es-JohanssonIndependent Director
- HCHoward ClowesIndependent Director
